Do Not Use Clindamycin Vaginal Cream and Suppository Simultaneously
There is no evidence supporting the simultaneous use of clindamycin vaginal cream and suppository, and this combination is not recommended in any established treatment guidelines. The CDC guidelines consistently present these formulations as alternative treatment options for bacterial vaginosis, not as complementary therapies to be used together 1, 2.
Why This Combination Is Not Recommended
Guidelines Present These as Alternatives, Not Combinations
The CDC STD Treatment Guidelines explicitly list clindamycin formulations as separate treatment regimens 2:
- Clindamycin cream 2%: one full applicator (5 g) intravaginally at bedtime for 7 days
- Clindamycin ovules 100 mg: intravaginally once at bedtime for 3 days
These are presented as distinct options with equivalent efficacy—one randomized trial found that cure rates did not differ significantly between clindamycin cream and clindamycin ovules 2. When treatments have similar efficacy, there is no rationale for combining them.
No Added Benefit, Potential for Increased Risk
Using both formulations simultaneously would:
- Double the local clindamycin exposure without evidence of improved efficacy
- Increase systemic absorption: The ovule formulation already has approximately 30% systemic absorption (sevenfold higher than cream at ~4%) 3. Combining them would further increase systemic drug levels unnecessarily
- Elevate risk of adverse effects: Both formulations carry the FDA black box warning about severe colitis and Clostridium difficile infection 4. Higher exposure increases this risk
- Increase vulvovaginal candidiasis risk: Already occurring in ~15% of patients with single-agent therapy 5
Clinical Practice Standard
The standard approach for bacterial vaginosis treatment is to:
- Choose ONE intravaginal clindamycin formulation (cream OR ovules/suppositories)
- Complete the full course as prescribed
- If treatment fails, switch to an alternative regimen (such as metronidazole) rather than adding or combining clindamycin formulations 2
Important Safety Considerations
Both clindamycin cream and ovules are oil-based and weaken latex condoms and diaphragms 1, 2. Using both would compound this effect and compromise barrier contraception.
The FDA label explicitly warns about severe colitis that can occur even with topical formulations due to systemic absorption 4. Combining formulations unnecessarily increases this serious risk without clinical benefit.
What to Do Instead
If bacterial vaginosis symptoms persist after completing one clindamycin regimen:
- Consider switching to metronidazole (oral or gel), which may be more efficacious than clindamycin cream 2
- Ensure the diagnosis is correct (rule out other causes of vaginal symptoms)
- Evaluate for recurrent infection rather than treatment failure
There is no clinical scenario where using both clindamycin cream and suppository together is appropriate or evidence-based.